OTC · Financial Statements
Medixall Group, Inc. (MDXL) Financial Statements
$0.01
OTC: MDXL
Market Cap $1.15M
Overview Financials Dividend Medixall Group, Inc. most recently reported annual revenue of $0, a net loss of $5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-6.0M $-7.0M $-7.0M $-4.0M Net Profit $-3.0M $-6.0M $-6.0M $-7.0M $-5.0M EPS $-0.05 $-0.07 $-0.06 $-0.06 $-0.04 Op Margin -127409.7% — -43561.3% -11035.1% -1265.6%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $1.0M $2.0M $1.0M $1.0M $0 Total Liabilities $1.0M $1.0M $1.0M $5.0M $7.0M Cash $0 $1.0M $0 $0 $0 Borrowings $0 $0 $0 $3.0M $4.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-2.0M $-4.0M $-5.0M $-4.0M $-1.0M Investing Cash Flow $0 $-1.0M $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $-1.0M $0 $0 Free Cash Flow $-2.0M $-4.0M $-5.0M $-4.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.28 FCF Yield -106.84% Quick Ratio 0.00 Interest Coverage -6.05 Return 1Y 43.59% Return 3Y 522.22% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .